|
Response surface model for anesthetic drug interactions
|
|
The operational multiple dosing half-life a key to defining drug accumulation in patients and to designing extended release dosage forms
|
|
A Mechanism-Based Population Pharmacokinetics Model of Erythropoietin in Premature Infants and Healthy Adults Following Multiple Intravenous Doses.
|
|
What Does It Take to Transform Real-World Data Into Real-World Evidence?
|
|
Quantitative Prediction of Human Pharmacokinetics for mAbs Exhibiting Target-Mediated Disposition
|
|
Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systemic review of papers published between 1990 and 2013
|
|
Fast screening of covariates in population models empowered by machine learning
|
|
Examining the Use of Real -World Evidence in the Regulatory Process
|
|
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy
|
